• Explore /
  • Poster
  • / Incidence, risk factors, and outcomes of immune-related adverse events (irAEs) in a prospective, pan-tumor population.

Incidence, risk factors, and outcomes of immune-related adverse events (irAEs) in a prospective, pan-tumor population.

Abstract Poster

Authors

null

Aanika Balaji

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD

Aanika Balaji , Stephanie Leigh Alden , Howard Li , Kabeer Munjal , Evan J. Lipson , Jarushka Naidoo , Laura Cappelli , Yasser Ged , Jean H. Hoffman-Censits , Rajat Mohindra , Rachel Garonce-Hediger , Tanguy Y. Seiwert , Sanjay Bansal , Laura Tang , G Scott Chandler , Mark Yarchoan , Chester Kao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other IO-Related Topics

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2662)

DOI

10.1200/JCO.2023.41.16_suppl.2662

Abstract #

2662

Poster Bd #

504

Abstract Disclosures

Similar Posters

First Author: Olisaemeka Ogbue

First Author: Patrick Walsh McGarrah

First Author: Chloe Lim

First Author: Jarushka Naidoo